Order Entry
Switzerland
ContactUsLinkComponent
 
Human recombinant LILRA2 (from HEK293)
 
Human recombinant LILRA2 (from HEK293)

 

  • Type de protéine/peptide:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Conditions de stockage:
    –20 °C
  • Teneur en endotoxines:
    Less than 1,0 EU per μg by the LAL method.
  • Activité biologique:
    Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before Lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human ANGPTL7, His Tag (Cat. No. AN7-H52H5) at 5 μg/ml(100 μl/well) can bind Biotinylated Human LILRA2, His,Avitag (Cat. No. LI2-H82E9) with a linear range of 0.625-5 μg/ml(QC tested).
  • ID de gène:
    Q8N149-1
  • Sans vecteur:
    Y
  • Exempt de protéase:
    Y
  • Exempt de substance animale:
    Y
  • Synonyme de protéine:
    ILT1CD85H|ILT-1|CD85h antigen|LIR-7|CD85H|CD85h|ILT1|LIR7|LILRA2|CD85 antigen-like family member H
  • Nom de la protéine/du peptide:
    LILRA2
  • Purity:
    >90%
  • Molecular weight:
    50,7 kDa
  • Niveau d'endotoxine:
    Low
  • Formulation:
    Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before Lyophilisation.
  • Absence de nucléases:
    Y
  • Température de transport:
    Powder,RT

 

Frequently Bought Together